Kevin Charles Gorman
Director at Neurocrine Biosciences · 16 reported transactions in 2 companies · latest trade May 19, 2026
Their trades
Sold | May 19, 2026 | May 19, 2026 close $154.36 → Oct 30, 2026 close $146.10. S&P 500 +3.0% over the same days. |
$37.82M
May 19, 2026 close $154.36 → Oct 30, 2026 close $146.10. S&P 500 +3.0% over the same days.